146 related articles for article (PubMed ID: 30053908)
1. Phenformin alone or combined with gefitinib inhibits bladder cancer via AMPK and EGFR pathways.
Huang Y; Zhou S; He C; Deng J; Tao T; Su Q; Darko KO; Peng M; Yang X
Cancer Commun (Lond); 2018 Jul; 38(1):50. PubMed ID: 30053908
[TBL] [Abstract][Full Text] [Related]
2. Metformin and gefitinib cooperate to inhibit bladder cancer growth via both AMPK and EGFR pathways joining at Akt and Erk.
Peng M; Huang Y; Tao T; Peng CY; Su Q; Xu W; Darko KO; Tao X; Yang X
Sci Rep; 2016 Jun; 6():28611. PubMed ID: 27334428
[TBL] [Abstract][Full Text] [Related]
3. Phenformin and ataxia-telangiectasia mutated inhibitors synergistically co-suppress liver cancer cell growth by damaging mitochondria.
Wu T; Zhou S; Qin M; Tang J; Yan X; Huang L; Huang M; Deng J; Xiao D; Hu X; Wu J; Yang X; Li G
FEBS Open Bio; 2021 May; 11(5):1440-1451. PubMed ID: 33742560
[TBL] [Abstract][Full Text] [Related]
4. Effects of metformin and phenformin on apoptosis and epithelial-mesenchymal transition in chemoresistant rectal cancer.
Park JH; Kim YH; Park EH; Lee SJ; Kim H; Kim A; Lee SB; Shim S; Jang H; Myung JK; Park S; Lee SJ; Kim MJ
Cancer Sci; 2019 Sep; 110(9):2834-2845. PubMed ID: 31278880
[TBL] [Abstract][Full Text] [Related]
5. Phenformin inhibits proliferation, invasion, and angiogenesis of cholangiocarcinoma cells via AMPK-mTOR and HIF-1A pathways.
Jaidee R; Kongpetch S; Senggunprai L; Prawan A; Kukongviriyapan U; Kukongviriyapan V
Naunyn Schmiedebergs Arch Pharmacol; 2020 Sep; 393(9):1681-1690. PubMed ID: 32383028
[TBL] [Abstract][Full Text] [Related]
6. Combination treatment with ionising radiation and gefitinib ('Iressa', ZD1839), an epidermal growth factor receptor (EGFR) inhibitor, significantly inhibits bladder cancer cell growth in vitro and in vivo.
Colquhoun AJ; Mchugh LA; Tulchinsky E; Kriajevska M; Mellon JK
J Radiat Res; 2007 Sep; 48(5):351-60. PubMed ID: 17609586
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the therapeutic potential of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in preclinical models of bladder cancer.
Dominguez-Escrig JL; Kelly JD; Neal DE; King SM; Davies BR
Clin Cancer Res; 2004 Jul; 10(14):4874-84. PubMed ID: 15269164
[TBL] [Abstract][Full Text] [Related]
8. Phenformin, But Not Metformin, Delays Development of T Cell Acute Lymphoblastic Leukemia/Lymphoma via Cell-Autonomous AMPK Activation.
Vara-Ciruelos D; Dandapani M; Russell FM; Grzes KM; Atrih A; Foretz M; Viollet B; Lamont DJ; Cantrell DA; Hardie DG
Cell Rep; 2019 Apr; 27(3):690-698.e4. PubMed ID: 30995468
[TBL] [Abstract][Full Text] [Related]
9. Geranylgeranyl transferase 1 inhibitor GGTI‑298 enhances the anticancer effect of gefitinib.
Liu BS; Dai XY; Xia HW; Xu HJ; Tang QL; Gong QY; Nie YZ; Bi F
Mol Med Rep; 2018 Oct; 18(4):4023-4029. PubMed ID: 30106149
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effects of metformin treatment in combination with gefitinib, a selective EGFR tyrosine kinase inhibitor, in LKB1 wild-type NSCLC cell lines.
Morgillo F; Sasso FC; Della Corte CM; Vitagliano D; D'Aiuto E; Troiani T; Martinelli E; De Vita F; Orditura M; De Palma R; Ciardiello F
Clin Cancer Res; 2013 Jul; 19(13):3508-19. PubMed ID: 23695170
[TBL] [Abstract][Full Text] [Related]
11. A novel mechanism of PPAR gamma induction via EGFR signalling constitutes rational for combination therapy in bladder cancer.
Mansure JJ; Nassim R; Chevalier S; Szymanski K; Rocha J; Aldousari S; Kassouf W
PLoS One; 2013; 8(2):e55997. PubMed ID: 23409107
[TBL] [Abstract][Full Text] [Related]
12. Lovastatin induces multiple stress pathways including LKB1/AMPK activation that regulate its cytotoxic effects in squamous cell carcinoma cells.
Ma L; Niknejad N; Gorn-Hondermann I; Dayekh K; Dimitroulakos J
PLoS One; 2012; 7(9):e46055. PubMed ID: 23029387
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the epidermal growth factor receptor in bladder cancer cells treated with the DNA-damaging drug etoposide markedly increases apoptosis.
Munk M; Memon AA; Nexo E; Sorensen BS
BJU Int; 2007 Jan; 99(1):196-201. PubMed ID: 17092291
[TBL] [Abstract][Full Text] [Related]
14. Phenformin Induces Cell Cycle Change, Apoptosis, and Mesenchymal-Epithelial Transition and Regulates the AMPK/mTOR/p70s6k and MAPK/ERK Pathways in Breast Cancer Cells.
Liu Z; Ren L; Liu C; Xia T; Zha X; Wang S
PLoS One; 2015; 10(6):e0131207. PubMed ID: 26114294
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effect of phenformin in non-small cell lung cancer (NSCLC) ionizing radiation treatment.
Wang J; Xia S; Zhu Z
Cell Biochem Biophys; 2015 Mar; 71(2):513-8. PubMed ID: 25312480
[TBL] [Abstract][Full Text] [Related]
16. Anticancer properties of novel pyrazole-containing biguanide derivatives with activating the adenosine monophosphate-activated protein kinase signaling pathway.
Zhou S; Xu L; Cao M; Wang Z; Xiao D; Xu S; Deng J; Hu X; He C; Tao T; Wang W; Guan A; Yang X
Arch Pharm (Weinheim); 2019 Sep; 352(9):e1900075. PubMed ID: 31339189
[TBL] [Abstract][Full Text] [Related]
17. Phenformin activates ER stress to promote autophagic cell death via NIBAN1 and DDIT4 in oral squamous cell carcinoma independent of AMPK.
Zhuang D; Wang S; Deng H; Shi Y; Liu C; Leng X; Zhang Q; Bai F; Zheng B; Guo J; Wu X
Int J Oral Sci; 2024 May; 16(1):35. PubMed ID: 38719825
[TBL] [Abstract][Full Text] [Related]
18. Metformin sensitizes human bladder cancer cells to TRAIL-induced apoptosis through mTOR/S6K1-mediated downregulation of c-FLIP.
Zhang T; Wang X; He D; Jin X; Guo P
Anticancer Drugs; 2014 Sep; 25(8):887-97. PubMed ID: 24714080
[TBL] [Abstract][Full Text] [Related]
19. Synergistic anti-tumor effects of liraglutide with metformin on pancreatic cancer cells.
Lu R; Yang J; Wei R; Ke J; Tian Q; Yu F; Liu J; Zhang J; Hong T
PLoS One; 2018; 13(6):e0198938. PubMed ID: 29897998
[TBL] [Abstract][Full Text] [Related]
20. Metformin amplifies chemotherapy-induced AMPK activation and antitumoral growth.
Rocha GZ; Dias MM; Ropelle ER; Osório-Costa F; Rossato FA; Vercesi AE; Saad MJ; Carvalheira JB
Clin Cancer Res; 2011 Jun; 17(12):3993-4005. PubMed ID: 21543517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
